The 2017 Alberta Digestive Disease Summit Program

PROGRAM SCHEDULE

This event is an Accredited Group Learning Activity (Section 1) as defined by the Maintenance of Certification program of The Royal College of Physicians and Surgeons of Canada, and accredited by the University of Calgary Office of Continuing Medical Education and Professional Development. Participants can claim up to a maximum of 14 study credits.

Claiming your credits: Visit MAINPORT https://mainport.royalcollege.ca to record your learning and outcomes.

Through an agreement between the Royal College of Physicians and Surgeons of Canada and the American Medical Association, physicians may convert Royal College MOC credits to AMA PRA Category 1 Credits™. Information on the process to convert Royal College MOC credit to AMA credit can be found at www.ama-assn.org/go/internationalcme.



ADDS 2017 Learning ObjectiveS: 

By the end of the conference, delegates will be able to: 

  1.  Demonstrate state‐of‐the‐art knowledge in the diagnosis and treatment of liver disease, inflammatory bowel disease and other gastrointestinal issues
  2. Articulate and integrate into their daily practice the key findings of current research into objective monitoring for patients with Crohn’s disease and ulcerative colitis, new treatments for IBD during pregnancy, and techniques for the management of Barrett’s esophagus and nonalcoholic fatty liver disease
  3. Describe practical colonoscopy techniques for the detection, assessment and treatment of colorectal tumours
  4. Define the interactions between diet and the human microbiome on a case to case basis, what role they play in the development of gastrointestinal inflammation and liver‐related disorders, and then employ current therapeutic advancements in microbiome manipulation
  5. Distill and apply in a clinical perspective the latest and most salient information presented during prominent international meetings in the fields of gastroenterology, hepatology, and nutrition studies
  6. Build their network of basic and clinical investigators in order to promote translational and clinical research relating to gastrointestinal disease

* all program sessions are subject to change

Friday, May 26, 2017

MORNING
Delegate Travel and Arrivals

11:30PM - 12:00PM
Delegate LUNCH  

12:00PM - 1:00 Pm

Symposium: Reaching New Horizons with Biosimilars in IBD

Moderator: Remo Panaccione, University of Calgary

12:00 PM - 12:15 PM

The Technical Skinny on Biosimilars: How, What, Why
Remo Panaccione, University of Calgary

Objectives:

  1. Review the similarities to originator molecules
  2. Define extrapolation and illustrate how extrapolation guides the use in IBD

12:15 PM - 12:30 PM

Biosimilar infliximab – The Hungary Experience that Alberta Needs to Know
Peter Lakatos, Semmelweis University, Hungary

Objectives:

  1. Discuss the experience European Countries had with the introduction of biosimilar Infliximab
  2. Describe the quality, safety, and efficacy data of biosimilar Infliximab

12:30 PM - 12:45 PM

Anti-TNF’s: STill The Best First Line Therapy for IBD Treatment
Karen Kroeker, University of Alberta

VIEW PRESENTATION

Objectives:

  1. Discuss the role of anti TNF therapy as first line in both Crohn’s Disease and Ulcerative Colitis

12:45 PM - 1:00 PM

Discussion: Effectiveness of the Biosimilar and the Value-Added Infusion Networks across Alberta

This symposium was co-developed with Pfizer Canada Inc. and was planned to achieve scientific integrity, objectivity and balance.

1:00 pm - 4:30 pm
CONCURRENT SESSIONS:BEST PRACTICE ABSTRACTS REVIEW COURSE

Objectives:
At the end of the session participants will be able to:

  1.  Cite many of the highest impact abstracts in clinical gastroenterology and hepatology in 2016-17;
  2. Translate emerging research in gastrointestinal and liver disease into improved therapeutic approaches and disease-management strategies in their clinical practice
  3. Describe the relevance of emerging science on daily clinical practice
  4.  Integrate novel therapies in clinical practice
  5. Incorporate state of the art therapies in daily endoscopy
  6. Implement novel educational strategies in teaching GI fellows

1:00 PM - 1:05 PM

Opening Remarks

1:05 PM - 1:17 PM

Four Selected Abstracts Relevant to Crohn's Disease
Shaalan Siffledeen, University of Alberta

VIEW PRESENTATION

1:17 PM - 1:22 PM

Q & A

1:22 PM - 1:34 PM

Greatest Hits in Pediatric GI
Jason Silverman, University of Alberta

VIEW PRESENTATION

1:34 PM - 1:39 PM

Q & A

1:39 PM - 1:51 PM

Updates in Hepatitis B and C
Carla Coffin, University of Calgary

VIEW PRESENTATION

1:51 PM - 1:56 PM

Q & A

1:56 PM - 2:08 PM

The Best GI Nutrition Abstracts in 2016/2017
Melanie Stapleton, University of Calgary

VIEW PRESENTATION

2:08 PM - 2:13 PM

Q & A

2:13 PM - 2:25 PM

GI Functional Disorders - Is Anything Really New?
Daniel Sadowski, University of Alberta

VIEW PRESENTATION

2:25 PM - 2:30 PM

Q & A

2:30 PM - 2:42 PM

State of the Art Therapeutic Updates in UC
Michael Stewart, University of Calgary

VIEW PRESENTATION

2:42 PM - 2:47 PM

Q & A

2:47 PM - 3:00 PM

Break

3:00 PM - 3:12 PM

Latest Advances in Non-Viral Liver Diseases (NAFLD and AI Hepatitis)
Juan Gonzalez-Abraldes, University of Alberta

VIEW PRESENTATION

3:12 PM - 3:17 PM

Q & A

3:17 PM - 3:29 PM

Education Advances Relevant to GI Trainees
Karen Kroeker, University of Alberta

VIEW PRESENTATION

3:29 PM - 3:34 PM

Q & A

3:34 PM - 3:46 PM

Best Basic Science Abstracts with Clinical Relevance
Humberto Jijon, University of Calgary

3:46 PM - 3:51 PM

Q & A

3:51 PM - 4:03 PM

Four Abstracts of RCTs That May Change Your Practice
Michel Sauve, Fort McMurray

4:03 PM - 4:08 PM

Q & A

4:08 PM - 4:20 PM

Therapeutic Endoscopy - Sate-of-the-Art Updates for Clinical Practice
Rajveer Hundal, Lethbridge

VIEW PRESENTATION

4:20PM - 4:25 PM

Q & A

4:20PM - 4:25 PM

Closing Comments

1:00 pm - 4:20 pm
concurrent sessions: NURSES' COURSE

Moderators: Christian Turbide, University of Calgary and Bobbi Sheppy, South Health Campus

1:00 PM - 1:05 PM

Opening Remarks

1:05 PM - 1:23 PM

How To Get a Patient Off of Their PPIs
Christian Turbide, Foothills Medical Centre

VIEW PRESENTATION

Objectives:

  1. Determine the drivers of GERD
  2. Discuss why should patients not stay on a PPI long term
  3. Develop a strategy to help educate the patient

1:23 PM - 1:30 PM

Q & A

1:30 PM - 1:47 PM

Understanding Biosimilars
Marie-Louise Martin, Alberta Health Services

VIEW PRESENTATION

Objectives:

  1. Understand the similarities between biosimilars and the reference biologic
  2. Develop familiarity with the approval process for biosimilars
  3. Identify and address common myths and current controversies relating to biosimilars

1:47 PM - 1:55 PM

Q & A

1:55 PM - 2:07 PM

Updates in Capsule Endoscopy
Tara Green, Alberta Health Services

VIEW PRESENTATION

Objectives:

  1. Understand current indications for capsule endoscopy
  2. Recognize potential risks associated with capsule endoscopy
  3. Review 2017 Clinical Practice Guidelines for Use of Capsule Endoscopy

2:07 PM - 2:20 PM

Q & A

2:20 PM - 2:45 PM

Endoscopy Quiz
Nauzer Forbes, University of Calgary

VIEW PRESENTATION

Objectives:

  1. Review the endoscopic presentations of common clinical conditions encountered in gastroenterology
  2. Discuss evidence-based approaches to endoscopic therapy

2:45 PM - 3:00 PM

Break

3:00 pm - 3:18 pm

Dietary Fiber in IBD
Maitreyi Raman, University of Calgary

VIEW PRESENTATION

Objectives:

  1. Describe the impact of dietary fiber on the GI mucosa
  2. Discuss the evidence for dietary fiber restriction in IBD
  3. Discuss practical strategies to optimize dietary intake in Crohn's disease

3:18 PM - 3:25 PM

Q & A

3:25 PM - 3:43 PM

Fatty Liver: What You Need to Know and What You Need to Do
Jessi Daniels, GI Medical Research & Associates Inc.

VIEW PRESENTATION

Objectives:

  1. Develop a diagnostic approach for fatty liver disease
  2. Prescribe appropriate treatment recommendations
  3. Discuss new developments in the management of fatty liver disease

3:43 PM - 1:50 PM

Q & A

3:50 PM - 4:08 PM

HCC: The Team Approach
Amy Baker, GI Medical Research & Associates Inc.

VIEW PRESENTATION

Objectives:

  1. How to Screen for hepatocellular carcinoma and how to confirm the diagnosis
  2. Treatments  available for hepatocellular carcinoma
  3. The nurses role in the coordination of care for hepatocellular carcinoma

4:08 PM - 4:15 PM

Q & A

4:15 PM - 4:20 PM

Closing Comments

4:30 PM - 5:00 PM
BREAK

5:00 PM - 6:00 PM
KEYNOTE SESSION: ALCOHOLIC LIVER DISEASE: A TALE OF TWO MALADIES

Michael Lucey, University of Wisconsin

VIEW PRESENTATION

Objectives: 

  1. Identify the definition of alcohol use disorder and alcoholic liver disease
  2. Recognize the role of excess alcohol use in the pathogenesis of alcoholic liver disease
  3. Formulate an approach to management that treats both the addiction to alcohol and the end-organ damage

5:45 PM - 6:00 PM

Q & A

6:00 PM-

BBQ DINNER & DANCE
Brewster Dance Barn


Saturday, May 27, 2017

7:00 AM - 7:30 AM
Breakfast

7:30 AM - 8:30 AM
SymposiuM: Managing Crohn's Disease: Has it Just Become Easier?


Moderator: Vipul Jairath, Western University

7:30 AM - 7:35 AM

Introduction
Vipul Jairath, Western University

7:35 AM - 7:44 AM

Interleukin 12 and Interleukin 23 Have a Major Role in IBD
Vipul Jairath, Western University

7:44 AM - 7:58 AM

Manipulating Interleukins as an Important Biologic Target in the Management of Crohn's Disease
Stephen Hanauer, Northwestern University

VIEW PRESENTATION

7:58 AM - 8:07 AM

The Alberta Experience: Real World Clinical Oucomes with Anit-IL 12/23 Agents in Crohn's Disease
Christopher Ma, University of Calgary

VIEW PRESENTATION

8:07 AM - 8:15 AM

An Update Management Algorithm of Crohn's Disease
Vipul Jairath, Western University

8:15 AM - 8:30 AM

Discussion

This symposium was co-developed with Janssen Inc. and was planned to achieve scientific integrity, objectivity and balance.

8:30 AM - 8:45 AM

Room Change

8:45 am -10:45 am
Plenary 1 - Excellence in Clinical Management      

Moderator: Anand Bala, Grey Nuns Hospital & Christian Turbide, University of Calgary

8:45 AM - 8:55 AM

Opening Remarks

8:55 AM - 9:17 AM

When Can You Be Certain Your Therapy of Choice Isn’t Working and Needs a Change? Then Do You Change the Dose or Change the Drug
Stephen Hanauer, Northwestern University

VIEW PRESENTATION

Objectives:

  1. Review assessment of clinical endpoints
  2. Discuss therapeutic drug monitoring in the setting of inadequate response
  3. Review therapeutic drug monitoring to assess loss of response

9:17 AM - 9:25 AM

Q & A

9:25 AM - 9:47 AM

Detection at Colonoscopy: How Good Can It Get?
Douglas Rex, Indiana University

VIEW PRESENTATION

Objectives:

  1. Know the definition of the adenoma detection rate (ADR)
  2. Know device and non-device methods to improve ADR

9:47 AM - 9:55 AM

Q & A

9:55 AM - 10:17 AM

Misplaced Priorities and Barrett’s Esophagus
Nicholas Shaheen, University of North Carolina at Chapel Hill

Objectives:

  1. Know the epidemiology of Barrett’s esophagus and esophageal adenocarcinoma
  2. Understand the correct management of patients with Barrett’s esophagus.

10:17 AM - 10:25 AM

Q & A

10:25 AM - 10:47 AM

Non-alcoholic Fatty Liver Disease 2017 Update
Zobair Younossi, Inova Fairfax Hospital

Objectives:

  1. Review the most up to date information about epidemiology and Non-alcoholic Fatty Liver Disease (NAFLD)
  2. Review the current state of the art diagnosis of non-alcoholic fatty liver disease
  3. Review current and future treatment of non-alcoholic steatohepatitis

10:47 AM - 10:55 AM

Q & A

10:55 AM - 11:10 AM

Break

11:10 am - 12:30 pm
Plenary 2 - focus on canadian research and clinical practice

11:10 AM - 11:32 AM

Next Generation Biologic Therapy in IBD: What does the future hold?
Remo Panaccione, University of Calgary

Objectives:

  1. Discuss new treatments in IBD
  2. Review the latest data that will impact your clinical practice in 2017 and beyond
  3. Discuss positioning of new therapies in IBD

11:32 AM - 11:40 AM

Q & A

11:40 AM - 12:02 pM

Therapeutic Manipulation of the Gut Microbiota in Patients with IBD
Karen Madsen, University of Alberta

VIEW PRESENTATION

Objectives:

  1. Understand the role the gut microbiome has in the pathogenesis of IBD
  2. Gain an understanding of how diet influences the microbiome
  3. Appreciate how diet could potentially be used to manipulate the microbiome and treat IBD

12:02 AM - 12:10 AM

Q & A

12:10 pM - 12:25 pM

The Digestive Health SCN: Your Strategic Clinical Network
Gilaad Kaplan, University of Calgary
Louise Morrin, Alberta Health Services

VIEW PRESENTATION

12:25 AM - 12:30 AM

Q & A

12:30 pm - 1:00 pm
DELEGATE LUNCH


1:00 pm - 2:00 pm
CONCURRENT SYMPOSIUM - MED Talks – IBD Evolution: Science, Strategies & Clinical Practice

Moderator: Brendan Halloran, University of Alberta

Objectives:

  1. Discuss the benefit/risks of biologics when speaking with patients
  2. Review pre-conception care and pregnancy in IBD
  3. Discuss IBD and Pregnancy management in Alberta.  

1:00 pm - 1:05 pm 

Opening Remarks

1:05 pM - 1:20 pM

Having IBD and Getting Pregnant: What Do I Need to Know in 2017
C. Janneke van der Woude, Erasmus University Medical Centre in Rotterdam

VIEW PRESENTATION

1:20 pM - 1:35 pM

IBD and Pregnancy Management in Alberta: Cutting-Edge Provincial Programs
Cynthia Seow, University of Calgary

VIEW PRESENTATION

1:35 pM - 1:45 pM

Discussing Benefit/Risks of Biologics When Speaking with Patients
Remo Panaccione, University of Calgary

1:45 pM - 2:00 pM

Interactive Panel Discussion

This symposium was co-developed with Takeda Canada Inc. and was planned to achieve scientific integrity, objectivity and balance.

1:00 pm - 2:00 pm
CONCURRENT SYMPOSIUM: Approaches Associated with More or Less Successful Implementation of HCV Elimination Strategies: A Tale of 2 Provinces

Lisa Barrett, Dalhousie University
Moderator: Robert Bailey, Royal Alexandra Hospital

Objectives:

  1. Describe HCV elimination plans in 2 provinces
  2. Review challenges and facilitators to implementation in 2 provinces

1:00 pm - 1:45 pm

Approaches Associated with More or Less Successful Implementation of HCV Elimination Strategies: A Tale of 2 Provinces

1:45 PM - 2:00 PM

Q & A

This symposium was co-developed with Merck and was planned to achieve scientific integrity, objectivity and balance.

2:00 pm - 3:30 pm
ASG Annual General Meeting

Download CAG Slides

2:00 pm - 3:30 pm
Fellows’ Exam Prep Course

3:30 pM - 6:00 pm
free time

6:00 pm - 7:00 pm
reception

7:00 PM - 
ASG NIGHT & DINNER

This Wild Spirit: Women in the Rocky Mountains of Canada
Special Guest Speaker: Colleen Skidmore, University of Alberta


Sunday, May 28, 2017

7:00 AM - 7:30 AM
Breakfast

7:30 AM - 8:30 AM
Concurrent SymposiUM: Keep CALM and Treat-To-Target: Optimizing IBD Care Today and Tomorrow

John Marshall, McMaster University
Remo Panaccione, University of Calgary

VIEW PRESENTATION

Objectives:

  1. Understand Treat to Target concepts in IBD: new data
  2. Understand the methods of optimizing therapy in 2017
  3. Understand and explore future therapeutic options

This symposium was co-developed AbbVie Canada Inc. and was planned to achieve scientific integrity, objectivity and balance.

8:15 AM - 8:30 AM

Q & A

7:30 AM - 8:30 AM
Concurrent SymposiUM: Only if HCV Was So Simple: Unique Patient Populations

Mark Swain, University of Calgary
Michael Lucey, University of Wisconsin
Moderator:
Robert Bailey, Royal Alexandra Hospital

Objectives:

  1. Review current and emerging treatment options for HCV using a case based approach
  2. Understand the application of new HCV therapies in specific patient populations
  3. Identify the impact of new agents on HCV liver transplant

8:15 AM - 8:30 AM

Q & A

This symposium was co-developed Gilead Sciences Canada and was planned to achieve scientific integrity, objectivity and balance.

8:30 am - 8:45 AM
ROOM CHANGE

8:45 am - 9:45 am
PLENARY SESSION 3- IBD at the Summit. Keeping Your Clinical Practice at Its Peak

Moderators: Richard Fedorak, University of Alberta and Robert Bailey, Royal Alexandra Hospital

VIEW PRESENTATION

8:45 AM - 9:45 AM
PANEL DISCUSSION

Panel Discussion
Vipul Jairath, Western University
John Marshall, McMaster University
C. Janneke van der Woude, Erasmus University Medical Centre in Rotterdam

Remo Panaccione, University of Calgary

Objectives:

  1. Present an international perspective when discussing new methods for treatment of patients with IBD in Alberta
  2. Identify the appropriate investigations required to manage difficult cases of Crohn's Disease and Ulcerative Colitis, according to current clinical practice guidelines

Session will include case studies with discussion following each. 15-20 minutes in total allocated for audience discussion, polling, and questions. 

9:45 AM - 10:00 AM
break

10:00 am - 11:30 am
PLENARY SESSION 4: EXcellence in clinical management

Moderator: Carla Coffin, University of Calgary

10:00 AM - 10:30 AM

Panel: Ask the Expert - Interactive Case based approach to NAFLD
Zobair Younossi, Inova Fairfax Hospital
Samuel Lee, University of Calgary
Robert Bailey, Royal Alexandra Hospital

VIEW PRESENTATION

Objectives:

  1. Assess patients at risk of NAFLD
  2. Understand diagnostic lab tests / imaging in assessing NAFLD
  3. Understand approach and evidence for current nutrition, lifestyle, surgical pharmacological management

Session will include case studies with discussion following each. 15-20 minutes in total allocated for audience discussion, polling, and questions. 

10:30 AM - 10:52 AM

Regimens and Resistance:  Interpreting and Implementing Global Guidelines in HCV
Lisa Barrett, Dalhousie University

Objectives:

  1. Describe new HCV resistance data from EASL
  2. Assess integration into new practice guidelines
  3. Discuss implications for broad implementation and clinical impact

10:52 AM - 11:00 AM

Q & A

11:00 AM - 11:22 AM

Colonoscopic Polypectomy: Toward Maximum Efficacy and Safety
Douglas Rex, Indiana University

VIEW PRESENTATION

Objectives:

  1. Understand the correct endoscopic assessment and description of lateral spreading tumors
  2. Know tools and methods for improving the safety and efficacy of endoscopic mucosal resection

11:22 AM - 11:30 AM

Q & A

11:30 AM - 11:35 AM
CONFERENCE CLOSING
DELEGATE TRAVEL/ LUNCH ON OWN